Member Info for ABUGFREEMIND

https://www.nasdaq.com/market-activity/stocks/tlsa

Could you please explain in laymens terms the reasoning behind your comments that the 48k and 80k marked as sells are actually buys. Thanks.

The number 02071180852 is ringing out being Sunday. I personally spoke to CEO to highlight previous posts on this board and was assured that the company is nearing IPO.

Hi, Messi I refer my posts of 17.44 and 17.49 advising that you contact Truspine which can help you to clarify your situation.

Messi, you can also check with Truspine to confirm you are on their register which can enable you to sell your shares when Truspine floats on the stockmarket.

Hi Messi , may I suggest you contact Truspine. Their telephone number is on their website and is genuine and ask for the CEO whom I am sure should be able to help you. I have recently spoke to the company who have assured me that they are now coming very close to IPO flotation. You have indiacted that your details are on the share certificate which means you will be able to sell your shares as soon as Truspine floats on the stock market

Nobody had bought this share since last update on the 30th June which has resulted in share price falling by 15% since last RNS update. Not looking like a very good investment at the moment.

Sorry meant to say that I am neither a ramper or de ramper. All the very best to all GDR investors.

Just been checking RNS from 22nd May 2020 which states .... " CE marking was achieved with performance studies and validations that will also support regulatory applications in other jurisdictions, such as Emergency Use Authorisation with the USA FDA and Emergency Use Assessment and Listing with the WHO. " Just to say it is now 7th July and it seems that an application for listing on the WHO approval list has still to be provided by GDR. Just for the record I invested in GDR on the 28th May mainly as a result of the excellent Invester proactive interview with the CEO and I am still holding. However, I am somewhat concerned like many other shareholders how some events regarding approval/sales are unfolding here. I am neither what you call a ramper / re- ramper and like all GDR investors simply desire that GDR be a roaring success.

Awating submission seems very self explanatory. If you are going to apply for anything some sort of application has to be submitted first in order to get the ball rolling. I might be wrong.

Awating submission seems to me that WHO have still to receive actual application from GDR. The other applications on the list seem to be either in progress requiring further information or close to the approval stage. I might be wrong. Can anyone else shed some more light on this?

According to link it states for Genedrive that they are still awaiting submission. Does this mean thay have yet to receive actual application for approval from Genedrive?

Thanks for the very informative posts here. As has already been posted here there are solid reasons to invest in IDH at the moment especially with their with their unique quanttiative assay anti body test now available on the commercial market. However, it seems that that this is still to be reflected in the actual share activity which is very low at the moment with most buys only coming when news hits the market. A nice consolidation of the share price between any actual news would therefore be very welcome here. Any other thoughts?

Do have a great deal of confidence in IDH and the fundamentals are excellent. Yes, totally agree, just requires some patience here with sales news due very soon.

Just bought in here recently. Why all the sells before news of contracts etc?

There are now 5.1 GHIF million shares that are due to to be admitted to trading on 22nd June 2020. Therefore just asking if these shares are likely to be held by GHIF as an investment in GDR. I know this this is very different from previous recent discounted placement and just looking for some views in this connection. Thanks.

Here is the actual post." Genedrive moves to positive cash position as Global Health Investment Fund converts 2014 loan into equity with additional orderly marketing agreement. Following completion, Genedrive will have gross cash balances of £8.6mln and debt of £2.6mln" https://lnkd.in/d9xH6iX

I am personally invested in GDR and listened to the investor event on Friday. Like many posters on here I agreee that the company has a unique PCR testing product with excellent potential . However, it also seems to me that concrete sales have to land sooner rather than later to enable the share price to head north again. All the best.

As to date we have a company called DIVOC in India whose website is two weeks old. Don't know if there are other
better known distribution channels in the background here. Any further information here?

I refer to GDR RNS from 5th May 2020. " Application will be made to the London Stock Exchange for the Placing Shares and such number of Broker Option Shares as may be subscribed for to be admitted to trading on AIM. It is expected that Admission will occur at 08.00 am on 28 May 2020 (or such other date as the Company, Peel Hunt and finnCap may agree, being no later than 11 June 2020).